Skip to content
Hantavirus.Watcher
Menu
← Back to ledger
AdvisoryPublished Jun 1 · 2026AI-classified · awaiting human verification

Experimental hantavirus drug ships to Europe as US passengers offered home quarantine

Read original atcidrap.umn.edu

SpainConfidence 90%Today

Emergency shipments of an experimental hantavirus drug are being sent to France, the Netherlands, and Spain for patients from the MV Hondius cruise ship, while US officials consider home quarantine for exposed American passengers in Nebraska.

Species mentioned

  • humans

Source articles

Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.

  • Primary
    Experimental hantavirus drug ships to Europe as US passengers offered home quarantine

    cidrap.umn.edu · 2026-06-01

    CIDRAP reported on May 29, 2026, that emergency shipments of the experimental antiviral drug favipiravir are being sent to France, the Netherlands, and Spain to treat hantavirus patients from the MV Hondius cruise ship. Fujifilm Pharmaceuticals donated 1,400 tablets. US officials are considering allowing American passengers, exposed to the Andes hantavirus and quarantined in Nebraska, to return home under 24/7 surveillance for the remainder of their six-week quarantine.

  • Reference
    CDC Alerts Clinicians About Potential for Imported Hantavirus Cases | MedPage Today

    vertexaisearch.cloud.google.com · 2026-06-01

    MedPage Today reported on May 12, 2026, that the CDC issued a Health Alert Network advisory on May 8, warning clinicians about potential imported hantavirus cases from the MV Hondius cruise ship outbreak. While the risk of broad US spread is low, early symptoms can be confused with other illnesses. Several state health departments, including Arizona, California, Georgia, Texas, and Virginia, are monitoring individuals. New Jersey and Maryland are also monitoring contacts from a flight with a symptomatic passenger, as is a Spanish woman.

  • Reference
    Hantavirus outbreak linked to cruise ship travel, Multi-locations

    vertexaisearch.cloud.google.com · 2026-06-01

    The World Health Organization (WHO) reported a total of 13 cases, including three deaths, linked to an Andes hantavirus outbreak on the MV Hondius cruise ship as of May 27, 2026. Eleven cases were laboratory-confirmed for Andes virus infection, and two are probable cases. The outbreak was first notified on May 2, 2026, and cases continue to be reported due to the virus's long incubation period of up to six weeks. Since May 13, three additional confirmed cases were reported from Canada, the Netherlands, and Spain. The previously reported inconclusive case from the United States was determined

  • Reference
    Hantavirus Patients Under Quarantine Could Go Home—If They Agree To 24/7 Surveillance, Report Says (Latest Updates) - Forbes

    vertexaisearch.cloud.google.com · 2026-06-01

    Americans quarantining in Nebraska after exposure to the Andes hantavirus on the M/V Hondius cruise ship were reportedly offered a deal to finish quarantine at home under 24/7 surveillance. A French national and two Spanish nationals tested positive after evacuation. The South African Department of Health confirmed the Andes virus strain. The WHO maintains the risk to the general population is low.

  • Reference
    Hantavirus outbreak 2026 - Public Health - European Commission

    vertexaisearch.cloud.google.com · 2026-06-01

    The European Commission was notified on May 2, 2026, of a cluster of severe respiratory illness aboard the MV Hondius, a Dutch-flagged wildlife expedition ship. Passengers and crew from 23 countries, including nine EU/EEA countries, were affected. The identified pathogen is Andes hantavirus, which is unique among hantaviruses for its potential for person-to-person transmission, typically requiring close and prolonged contact. The risk to the general population of the EU/EEA is assessed as very low. The Commission is actively involved in preparedness and response, including supporting the emer

Reminder

This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.